Brock malignancy risk calculator for pulmonary nodules: validation outside a lung cancer screening population
Abstract
Objective To assess the performance of the Brock malignancy risk model for pulmonary nodules detected in routine clinical setting. Methods In two academic centres in the Netherlands, we established a list of patients aged ≥40 years who received a chest CT scan between 2004 and 2012, resulting in 16 850 and 23 454 eligible subjects. Subsequent diagnosis of lung cancer until the end of 2014 was established through linking with the National Cancer Registry. A nested case–control study was performed (ratio 1:3). Two observers used semiautomated software to annotate the nodules. The Brock model was separately validated on each data set using ROC analysis and compared with a solely size-based model. Results After the annotation process the final analysis included 177 malignant and 695 benign nodules for centre A, and 264 malignant and 710 benign nodules for centre B. The full Brock model resulted in areas under the curve (AUCs) of 0.90 and 0.91, while the size-only model yielded significantly lower AUCs of 0.88 and 0.87, respectively (p99%. Discussion The Brock model shows high predictive discrimination of potentially malignant and benign nodules when validated in an unselected, heterogeneous clinical population. The high NPV may be used to decrease the number of nodule follow-up examinations.Keywords
Funding Information
- KWF Kankerbestrijding
This publication has 16 references indexed in Scilit:
- Risk of malignancy in pulmonary nodules: A validation study of four prediction modelsLung Cancer, 2015
- Predictive Accuracy of the PanCan Lung Cancer Risk Prediction Model -External Validation based on CT from the Danish Lung Cancer Screening TrialEuropean Radiology, 2015
- Towards a close computed tomography monitoring approach for screen detected subsolid pulmonary nodules?European Respiratory Journal, 2014
- Probability of Cancer in Pulmonary Nodules Detected on First Screening CTNew England Journal of Medicine, 2013
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningNew England Journal of Medicine, 2011
- Advantages of the nested case-control design in diagnostic researchBMC Medical Research Methodology, 2008
- A Clinical Model To Estimate the Pretest Probability of Lung Cancer in Patients With Solitary Pulmonary NodulesChest, 2007
- Clinical Prediction Model To Characterize Pulmonary NodulesChest, 2005
- The Probability of Malignancy in Solitary Pulmonary NodulesArchives of internal medicine (1960), 1997
- Nested Case-Control StudiesPreventive Medicine, 1994